Literature DB >> 2924301

Changes in activities of free radical detoxifying enzymes in kidneys of male Syrian hamsters treated with estradiol.

D Roy1, J G Liehr.   

Abstract

Target organ-specific estrogen-induced DNA adducts were previously shown to precede renal carcinogenesis in Syrian hamsters. Because estrogens induced these DNA modifications, but were not part of the adduct structure, free radical activation of endogenous electrophiles was postulated as a mechanism of tumor induction by estrogens. In the present study, the activities of enzymes which detoxify reactive intermediates were studied in liver and kidney of hamsters treated with estradiol for 1, 2, and 4 mo and in untreated controls. These studies were done to detect oxidative stress in the target organ of carcinogenesis. In the estrogen-exposed hamster kidney (1, 2, and 4 mo), activities of glutathione peroxidases I and II were significantly increased. The activity of catalase was decreased compared to those in untreated controls. In livers which are not the target organ of carcinogenesis, treatment of hamsters with estrogen for 1, 2, and 4 mo resulted in changes of activities of glutathione peroxidases I and II and catalase, which were opposite to the pattern found in the kidney. Activities of superoxide dismutase, glutathione reductase, glucose-6-phosphate dehydrogenase, gamma-glutamyl transpeptidase, and glutathione transferase in estradiol-treated hamster liver and kidney did not differ significantly from those in either liver or kidney of untreated age-matched controls. Fluorescent products of lipid peroxidation more than doubled in the kidney, but not in the liver of hamsters treated with estradiol for 1 mo. It is concluded that the increases in glutathione, in the activity of glutathione peroxidase, and in products of lipid peroxidation in the kidneys of hamsters treated chronically with estrogen all point towards elevated levels of oxidative stress.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2924301

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Oxidant-antioxidant status in colorectal cancer patients-Before and after treatment.

Authors:  Sharmila Upadhya; Subramanya Upadhya; S Krishna Mohan; K Vanajakshamma; Mamatha Kunder; Seema Mathias
Journal:  Indian J Clin Biochem       Date:  2004-07

2.  Effects of estradiol benzoate and progesterone on superoxide dismutase activity in the rat liver.

Authors:  J Kasapović; S B Pajović; D T Kanazir; J V Martinović
Journal:  J Endocrinol Invest       Date:  1997-04       Impact factor: 4.256

3.  Protective effect of estrogens and catecholestrogens against peroxidative membrane damage in vitro.

Authors:  M Lacort; A M Leal; M Liza; C Martín; R Martínez; M B Ruiz-Larrea
Journal:  Lipids       Date:  1995-02       Impact factor: 1.880

Review 4.  Potential biomarkers associated with oxidative stress for risk assessment of colorectal cancer.

Authors:  Paramita Mandal
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-02-22       Impact factor: 3.000

5.  Target organ-specific inactivation of drug metabolizing enzymes in kidney of hamsters treated with estradiol.

Authors:  D Roy; J G Liehr
Journal:  Mol Cell Biochem       Date:  1992-03-04       Impact factor: 3.396

6.  Antioxidant status and lipid peroxidation in athymic mice xenografted with two types of human tumors.

Authors:  A S Gauchez; J Riondel; M Jacrot; J Calop; A Favier
Journal:  Biol Trace Elem Res       Date:  1995 Jan-Mar       Impact factor: 3.738

7.  Oxidative stress-related genotypes, fruit and vegetable consumption and breast cancer risk.

Authors:  Yulin Li; Christine B Ambrosone; Marjorie J McCullough; Jiyoung Ahn; Victoria L Stevens; Michael J Thun; Chi-Chen Hong
Journal:  Carcinogenesis       Date:  2009-03-02       Impact factor: 4.944

8.  Association between polymorphisms in glutathione peroxidase and selenoprotein P genes, glutathione peroxidase activity, HRT use and breast cancer risk.

Authors:  Catherine Méplan; Lars Ove Dragsted; Gitte Ravn-Haren; Anne Tjønneland; Ulla Vogel; John Hesketh
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.